TWST:NASDAQ
Twist Bioscience Corp
$155.56
arrow_upward
+8.73%(+12.49) 1D
$158.00
arrow_upward
+1.57% (+2.44)bedtimeAfter hours
Closed: Sep 17, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$151.43
High
$163.70
Low
$150.00
Mkt. cap
10.31B
Avg. vol.
1.68M
Volume
3.37M
52-wk high
$163.70
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
Open
$151.43
High
$163.70
Low
$150.00
Mkt. cap
10.31B
Avg. vol.
1.68M
Volume
3.37M
52-wk high
$163.70
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Yahoo Finance
·
4 hours ago
TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short
Timothy Sykes
·
5 hours ago
Twist Bioscience Stock Jumps On Lilly AI Drug Discovery Deal
Stock Titan
·
5 hours ago
Twist Bioscience (NASDAQ: TWST) holder eyes $44.7M stock sale
StocksToTrade
·
7 hours ago
Twist Bioscience Stock Jumps As Lilly AI Deal Fuels Growth Story
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp